Tag Archives: Psychedelic

TDR’s Top 5 Psychedelic Developments For The Week Of February 28

Welcome to TDR’s review of the Top 5 Psychedelic developments for the week of February 28. Aside from presenting a synopsis of events, we provide market commentary to summarize the week that was for publicly-listed companies. 5. Mydecine Reports Positive Pre-IND Meeting With FDA For MYCO-001 Smoking Cessation Study Mydecine Innovations Group (NEO: MYCO) (OTCMKTS: MYCOF) announced a positive meeting with the Food and Drug Administration (FDA) regarding their Investigational New Drug (IND) and breakthrough therapy status applications. The data from John Hopkins University’s ongoing studies assessing psychedelic-assisted […]

Read more